SENS
Senseonics Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.63
−2.73%Year over year
Reported trailing growth
- Revenue
- +90.6%
- EBITDA
- -71.7%
- EBIT
- -66.9%
- EPS
- -5.3%
- Free cash flow
- -76.7%
- Operating cash flow
- -76.3%
Forward estimates
Based on analyst estimates
- Revenue
- +62.2%
- EBITDA
- -5.6%
- EPS
- +11.9%
Three-year CAGR
- Revenue
- +29.1%
- EBITDA
- +8.8%
- EBIT
- +8.7%
- Net income
- +12.1%
- EPS
- +33.6%
- Free cash flow
- +3.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026